<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117859">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02155569</url>
  </required_header>
  <id_info>
    <org_study_id>atauni8</org_study_id>
    <nct_id>NCT02155569</nct_id>
  </id_info>
  <brief_title>Extraperitoneal Versus Transperitoneal Cesarean Section</brief_title>
  <official_title>Extraperitoneal Versus Transperitoneal Cesarean Section: A Prospective Randomized Comparison</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ataturk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ataturk University</source>
  <oversight_info>
    <authority>Turkey: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim  of the study is to compare post operative morbidity between extra peritoneal
      cesarian and trans peritoneal cesarean section.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>post operative pain</measure>
    <time_frame>One hour before cesarean and 24 hour postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Perceived and pain scores will be measured by an visual analog scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>delivery time</measure>
    <time_frame>2 minutes after delivery</time_frame>
    <safety_issue>No</safety_issue>
    <description>skin incision to delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>operation time</measure>
    <time_frame>5 minutes postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>skin incision to skin closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemoglobin differences</measure>
    <time_frame>one hour before cesarean, 48 hour postoperatively</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>need for extra analgesic</measure>
    <time_frame>48 hour</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nausea</measure>
    <time_frame>48 hour</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vomiting</measure>
    <time_frame>48 hour</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>thoracic and shoulder pain</measure>
    <time_frame>48 hour</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urogenital distress measured by Urogenital Distress Inventory</measure>
    <time_frame>One hour before cesarean and 24 hour postoperatively</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral intake</measure>
    <time_frame>48 hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>The percentage of patients who tolerates oral intake. Oral intake will be allowed 4-6 hour after cesarean for intraperitoneal group. For extra peritoneal group it will be allowed when patient passed gas.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Cesarean, Extraperitoneal</condition>
  <arm_group>
    <arm_group_label>Transperitoneal Cesarean</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Extraperitoneal Cesarean</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extraperitoneal Cesarean</intervention_name>
    <description>Pfannenstiel incision, paravesical approach to lower uterine segment extraperitoneally and Kerr incision for uterine entry</description>
    <arm_group_label>Extraperitoneal Cesarean</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transperitoneal Cesarean</intervention_name>
    <description>Pfannenstiel-Kerr technique for laparatomy and uterine entry</description>
    <arm_group_label>Transperitoneal Cesarean</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective cesarean (primary or first repeated)

        Exclusion Criteria:

          -  emergent cesarean

          -  macrosomia (fetal weight &gt; 4500 g)

          -  history of major abdominal surgery

          -  suspected abdominal presentation

          -  placenta previa
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 4, 2014</lastchanged_date>
  <firstreceived_date>June 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ataturk University</investigator_affiliation>
    <investigator_full_name>RagÄ±p Atakan Al</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Cesarean, extraperitoneal</keyword>
  <keyword>Cesarean</keyword>
  <keyword>Pain</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
